Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
The closing price of Climb Bio Inc (NASDAQ: CLYM) was $1.87 for the day, down -2.60% from the previous closing price of $1.92. In other words, the price has decreased by -$2.60 from its previous closing price. On the day, 3.35 million shares were traded. CLYM stock price reached its highest trading level at $1.99 during the session, while it also had its lowest trading level at $1.79.
Ratios:
Our analysis of CLYM’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 57.73 and its Current Ratio is at 57.73. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Leerink Partners on December 02, 2024, initiated with a Outperform rating and assigned the stock a target price of $10.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 19 ’24 when Pimblett Emily sold 1,235 shares for $2.02 per share. The transaction valued at 2,495 led to the insider holds 11,329 shares of the business.
Pimblett Emily sold 1,191 shares of CLYM for $9,741 on Sep 20 ’24. The CHIEF ACCOUNTING OFFICER now owns 7,564 shares after completing the transaction at $8.18 per share. On Jul 22 ’24, another insider, Morisset Valerie, who serves as the EVP, R&D AND CSO of the company, sold 69,005 shares for $8.03 each. As a result, the insider received 554,170 and left with 31,317 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CLYM now has a Market Capitalization of 125851000 and an Enterprise Value of -67584568.
Stock Price History:
The Beta on a monthly basis for CLYM is -0.26, which has changed by -0.3469388 over the last 52 weeks, in comparison to a change of 0.23147523 over the same period for the S&P500. Over the past 52 weeks, CLYM has reached a high of $11.55, while it has fallen to a 52-week low of $1.73. The 50-Day Moving Average of the stock is -33.46%, while the 200-Day Moving Average is calculated to be -66.69%.
Shares Statistics:
CLYM traded an average of 346.89K shares per day over the past three months and 493820 shares per day over the past ten days. A total of 67.22M shares are outstanding, with a floating share count of 51.47M. Insiders hold about 23.44% of the company’s shares, while institutions hold 71.05% stake in the company. Shares short for CLYM as of 1735603200 were 4816219 with a Short Ratio of 13.88, compared to 1732838400 on 4895678. Therefore, it implies a Short% of Shares Outstanding of 4816219 and a Short% of Float of 9.879999999999999.
